Загрузка...
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
For 50 years ago was introduced L-3,4-dihydroxyphenylalanine (L-dopa) in Parkinson's disease treatment and during this significant advances has been done but what trigger the degeneration of the nigrostriatal system remain unknown. There is a general agreement in the scientific community that m...
Сохранить в:
| Опубликовано в: : | Neural Regen Res |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5514859/ https://ncbi.nlm.nih.gov/pubmed/28761417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.208560 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|